SC 13D/A 1 d237940dsc13da.htm SC 13D/A SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)*

 

 

Entravision Communications Corporation

(Name of Issuer)

Class A Common Stock, $0.0001 par value

(Title of Class of Securities)

29382R107

(CUSIP NUMBER)

Christopher D. Moore

Angelo, Gordon & Co, L.P.

245 Park Avenue, 26th Floor

New York, NY 10167

Tel. No.: (212) 692-2009

COPIES TO:

Jason Daniel

Akin Gump Strauss Hauer & Feld LLP

2300 N. Field Street

Suite 1800

Dallas, TX 75201

(214) 969-4209

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

February 11, 2021

(Date of event which requires filing of this statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D/A, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g) check the following box ☐

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

* 

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

 

 


CUSIP No. 29382R107    13D        

 

  1   

NAME OF REPORTING PERSONS

 

Angelo, Gordon & Co., L.P.

  2   

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3   

SEC USE ONLY

 

  4   

SOURCE OF FUNDS*

 

AF

  5   

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  6   

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

    7    

SOLE VOTING POWER

 

2,975,258

    8    

SHARED VOTING POWER

 

0

    9    

SOLE DISPOSITIVE POWER

 

2,975,258

  10    

SHARED DISPOSITIVE POWER

 

0

11   

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,975,258

12   

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

13   

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.97%*

14   

TYPE OF REPORTING PERSON*

 

IA, PN

 

*

Based on 59,905,386 shares of Common Stock of the Issuer outstanding as of November 2, 2020, as reported in the Issuer’s Form 10-Q filed with the SEC on November 6, 2020.


CUSIP No. 29382R107    13D        

 

  1   

NAME OF REPORTING PERSONS

 

AG Partners, LLC

  2   

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3   

SEC USE ONLY

 

  4   

SOURCE OF FUNDS*

 

AF

  5   

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  6   

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

    7    

SOLE VOTING POWER

 

2,975,258

    8    

SHARED VOTING POWER

 

0

    9    

SOLE DISPOSITIVE POWER

 

2,975,258

  10    

SHARED DISPOSITIVE POWER

 

0

11   

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,975,258

12   

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

13   

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.97%*

14   

TYPE OF REPORTING PERSON*

 

HC, OO

 

*

Based on 59,905,386 shares of Common Stock of the Issuer outstanding as of November 2, 2020, as reported in the Issuer’s Form 10-Q filed with the SEC on November 6, 2020.


CUSIP No. 29382R107    13D        

 

  1   

NAME OF REPORTING PERSONS

 

JAMG LLC

  2   

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3   

SEC USE ONLY

 

  4   

SOURCE OF FUNDS*

 

AF

  5   

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  6   

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

    7    

SOLE VOTING POWER

 

2,975,258

    8    

SHARED VOTING POWER

 

0

    9    

SOLE DISPOSITIVE POWER

 

2,975,258

  10    

SHARED DISPOSITIVE POWER

 

0

11   

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,975,258

12   

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

13   

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.97%*

14   

TYPE OF REPORTING PERSON*

 

HC, OO

 

*

Based on 59,905,386 shares of Common Stock of the Issuer outstanding as of November 2, 2020, as reported in the Issuer’s Form 10-Q filed with the SEC on November 6, 2020.


CUSIP No. 29382R107    13D        

 

  1   

NAME OF REPORTING PERSONS

 

Josh Baumgarten

  2   

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3   

SEC USE ONLY

 

  4   

SOURCE OF FUNDS*

 

AF

  5   

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  6   

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

    7    

SOLE VOTING POWER

 

0

    8    

SHARED VOTING POWER

 

2,975,258

    9    

SOLE DISPOSITIVE POWER

 

0

  10    

SHARED DISPOSITIVE POWER

 

2,975,258

11   

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,975,258

12   

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

13   

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.97%*

14   

TYPE OF REPORTING PERSON*

 

IN, HC

 

*

Based on 59,905,386 shares of Common Stock of the Issuer outstanding as of November 2, 2020, as reported in the Issuer’s Form 10-Q filed with the SEC on November 6, 2020.


CUSIP No. 29382R107    13D        

 

  1   

NAME OF REPORTING PERSONS

 

Adam Schwartz

  2   

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3   

SEC USE ONLY

 

  4   

SOURCE OF FUNDS*

 

AF

  5   

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  6   

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

    7    

SOLE VOTING POWER

 

0

    8    

SHARED VOTING POWER

 

2,975,258

    9    

SOLE DISPOSITIVE POWER

 

0

  10    

SHARED DISPOSITIVE POWER

 

2,975,258

11   

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,975,258

12   

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

13   

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.97%*

14   

TYPE OF REPORTING PERSON*

 

IN, HC

 

*

Based on 59,905,386 shares of Common Stock of the Issuer outstanding as of November 2, 2020, as reported in the Issuer’s Form 10-Q filed with the SEC on November 6, 2020.


AMENDMENT NO. 8 TO SCHEDULE 13D

This Amendment No. 8 to Schedule 13D amends and supplements the Schedule 13D filed by (i) Angelo, Gordon & Co., L.P., a Delaware limited partnership (“Angelo Gordon”), (ii) AG Partners, LLC, a Delaware limited liability company (“AG Partners”), (iii) JAMG LLC, a Delaware limited liability company (“JAMG”), (iv) Josh Baumgarten and (v) Adam Schwartz with the Securities and Exchange Commission (the “SEC”) on on September 9, 2019, as amended by the Amendment No. 1 to Schedule 13D (the “Amendment No. 1”), filed May 12, 2020 and Amendment No. 2 to Schedule 13D (the “Amendment No. 2”), filed May 15, 2020, Amendment No. 3 to Schedule 13D (the “Amendment No. 3”), filed October 5, 2020, Amendment No. 4 to Schedule 13D (the “Amendment No. 4”), filed October 16, 2020, Amendment No. 5 to Schedule 13D (the “Amendment No. 5”), filed December 3, 2020, Amendment No. 6 to Schedule 13D (the “Amendment No. 6”), filed January 12, 2021 and Amendment No. 7 to Schedule 13D (the “Amendment No. 7”), filed February 4, 2021 (the “Schedule 13D”).

This Amendment No. 8 amends and supplements the Schedule 13D as specifically set forth herein.

All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

 

Item 5.

Interest in Securities of the Issuer

Item 5 of the Schedule 13D is hereby amended and restated to read as follows:

(a) - (b) Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference. Such information is based on 59,905,386 shares of Common Stock outstanding as of November 2, 2020, as reported in the Issuer’s Form 10-Q filed with the SEC on November 6, 2020

Angelo Gordon, in its capacity as investment manager to the Accounts, has sole power to vote 2,975,258 shares of Common Stock and the power to dispose of 2,975,258 shares of Common Stock held in the Accounts. As the general partner of Angelo Gordon, AG Partners may be deemed to have the sole power to vote 2,975,258 shares of Common Stock and the power to dispose of 2,975,258 shares of Common Stock held in the Accounts. As the managing member of AG Partners, JAMG may be deemed to have the sole power to vote 2,975,258 shares of Common Stock and the power to dispose of 2,975,258 shares of Common Stock held in the Accounts. As the co-managing member of JAMG and the co-chief executive officer of Angelo Gordon, Mr. Baumgarten may be deemed to have shared power to vote 2,975,258 shares of Common Stock and the shared power to dispose of 2,975,258 shares of Common Stock held in the Accounts. As the co-managing member of AG Partners and the co-chief executive officer of Angelo Gordon, Mr. Schwartz may be deemed to have shared power to vote 2,975,258 shares of Common Stock and the shared power to dispose of 2,975,258 shares of Common Stock held in the Accounts.

(c) Transactions in the shares of Common Stock by the Reporting Persons since February 4, 2021 are listed in Annex A attached hereto, which is incorporated herein by reference.

(d) Not Applicable.

(e) On February 11, 2021, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Issuer’s Common Stock.

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6 of the Schedule 13D is supplemented as follows:

The Accounts have established a position in cash-settled equity swaps which in the aggregate represent economic exposure comparable to a notional interest in 2,923,551 shares of Common Stock (representing economic exposure comparable to approximately 4.88% of the outstanding shares of Common Stock). Under the terms of the swaps, (i) the Accounts will be obligated to pay to the counterparty any negative price performance of the specified notional number of shares of Common Stock subject to the swaps as of the expiration date of such swaps, plus interest rates set forth in the applicable contracts, and (ii) the counterparty will be obligated to pay the Accounts any positive price performance of the specified notional number of shares of Common Stock subject to the swaps as of the


expiration date of the swaps. All balances will be settled in cash. The Reporting Persons’ counterparty is Credit Suisse. The Reporting Persons may enter into additional swaps for additional securities of the Issuer depending on market conditions. The swaps do not give the Reporting Persons or the Accounts direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparty thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership of any shares of Common Stock that may be referenced in the swap contracts or shares of Common Stock or other securities or financial instruments that may be held from time to time by any counterparty to the contracts.


Signature

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: February 16, 2021

 

ANGELO, GORDON & CO., L.P.
By:   AG Partners, LLC
  Its General Partner
By:   JAMG LLC
  Its Managing Member
By:   Josh Baumgarten
  Its Co-Managing Member
By:  

/s/ Christopher D. Moore

  Christopher D. Moore
  Attorney-in-Fact
AG PARTNERS, LLC
By:   JAMG LLC
  Its Managing Member
By:   Josh Baumgarten
  Its Co-Managing Member
By:  

/s/ Christopher D. Moore

  Christopher D. Moore
  Attorney-in-Fact
JAMG LLC
By:   Josh Baumgarten
  Its Co-Managing Member
By:  

/s/ Christopher D. Moore

  Christopher D. Moore
  Attorney-in-Fact


JOSH BAUMGARTEN
By:  

/s/ Christopher D. Moore

  Christopher D. Moore
  Attorney-in-Fact
ADAM SCHWARTZ
By:  

/s/ Christopher D. Moore

  Christopher D. Moore
  Attorney-in-Fact


Annex A

The following table sets forth all transactions by the Reporting Persons (on behalf of the Accounts) with respect to shares of Common Stock effected since February 4, 2021, inclusive of any transactions effected through 9:00 a.m., New York City time, on February 16, 2021. Except as otherwise noted below, all such transactions were purchases of Common Stock effected in the open market, and the table excludes commissions paid in per share prices.

 

Trade Date

   Amount Purchased/(Sold)      Price         

02/04/2021

     (57,518      3.25        (1

02/05/2021

     (39,215      3.20        (2

02/09/2021

     (64,267      3.51        (3

02/10/2021

     (75,488      3.42        (4

02/11/2021

     (739,446      3.31        (5

 

(1)

The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.36, inclusive. The reporting persons undertake to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5).

(2)

The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.17 to $3.24, inclusive.

(3)

The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.56, inclusive.


(4)

The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.38 to $3.49, inclusive.

(5)

The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.56, inclusive.